Bezafibrate is a lipid-lowering agent, indicated for the treatment of hyperlipidemia.
Unipharm’s generic Bezafibrate Tablets have been manufactured and marketed in Israel since 1990.
ATC4: C10AB
Strengths: 200 mg
Dosage form: Tablets
Out-licensing is offered for all international markets*
Zone IVb stability data is available
* Product availability is subject to patent restrictions in countries where applicable patents are in effect
